Rady A Johnson, Executive Vice President of Pfizer Inc (PFE), was reported to have engaged in a transaction involving the company's stock on October 10, 2024. The specific details of the transaction, such as the action type, number of shares, nature of shares, transaction price, and total value, were not disclosed in the announcement. The report did not provide information on the number of shares Johnson held after the action. This transaction is part of the routine disclosures that executive officers are required to make and could be of interest to investors following Pfizer's stock.

Rady A Johnson, Executive Vice President of Pfizer Inc (PFE), was reported to have engaged in a transaction involving the company's stock on October 10, 2024. The specific details of the transaction, such as the action type, number of shares, nature of shares, transaction price, and total value, were not disclosed in the announcement. The report did not provide information on the number of shares Johnson held after the action. This transaction is part of the routine disclosures that executive officers are required to make and could be of interest to investors following Pfizer's stock.